Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin Effect on Influenza Vaccine Responses
NCT06024096Phase 4Completed
- Sponsor
- Emory University
- Start
- Sep 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in vaccine response (2 arms), sponsored by Emory University. Primary endpoint: Magnitude of the Antibody (Ab) Response to QIV at 29 days. Started Sep 2023; status: completed.
02
Drugs
atorvastatin
03
Conditions
vaccine response
Beyond the preview
Go deeper on NCT06024096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06024096.